261 related articles for article (PubMed ID: 300400)
1. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.
Wong CY; Woodruff JJ; Woodruff JF
J Immunol; 1977 Apr; 118(4):1165-9. PubMed ID: 300400
[TBL] [Abstract][Full Text] [Related]
2. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
Wong CY; Woodruff JJ; Woodruff JF
J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399
[TBL] [Abstract][Full Text] [Related]
3. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. III. Role of sex.
Wong CY; Woodruff JJ; Woodruff JF
J Immunol; 1977 Aug; 119(2):591-7. PubMed ID: 301899
[No Abstract] [Full Text] [Related]
4. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
[TBL] [Abstract][Full Text] [Related]
5. Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes.
Huber SA; Job LP; Woodruff JF
Am J Pathol; 1980 Mar; 98(3):681-94. PubMed ID: 6244737
[TBL] [Abstract][Full Text] [Related]
6. Sex-related differences in the rapid production of cytotoxic spleen cells active against uninfected myofibers during Coxsackievirus B-3 infection.
Huber SA; Job LP; Auld KR; Woodruff JF
J Immunol; 1981 Apr; 126(4):1336-40. PubMed ID: 7204968
[TBL] [Abstract][Full Text] [Related]
7. Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
Koszinowski U; Thomssen R
Eur J Immunol; 1975 Apr; 5(4):245-51. PubMed ID: 1086229
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
Ting CC; Kirchner H; Rodrigues D; Park JY; Herberman RB
J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic macrophages: a rapid nonspecific response to viral infection.
Rodda SJ; White DO
J Immunol; 1976 Dec; 117(6):2067-72. PubMed ID: 1086869
[TBL] [Abstract][Full Text] [Related]
10. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
Dennert G; Hatlen LE
J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated allograft responses in vitro. VI. Studies on macrophage-mediated cytotoxicity.
Pfizenmaier K; Trostmann H; Röllinghoff M; Wagner H
Immunology; 1975 Dec; 29(6):967-76. PubMed ID: 1081494
[TBL] [Abstract][Full Text] [Related]
12. Specific immune lysis of paramyxovirus-infected cells by H-2-compatible thymus-derived lymphocytes.
Doherty PC; Zinkernagel RM
Immunology; 1976 Jul; 31(1):27-32. PubMed ID: 194830
[TBL] [Abstract][Full Text] [Related]
13. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
Paciucci PA; Macphail S; Bach FH; Zarling JM
J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
[TBL] [Abstract][Full Text] [Related]
14. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
Welsh RM; Haspel MV; Parker DC; Holmes KV
J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
[TBL] [Abstract][Full Text] [Related]
15. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
16. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
James SL; Lazdins JK; Hieny S; Natovitz P
J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
[TBL] [Abstract][Full Text] [Related]
17. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. I. Kinetics of induction in vitro and yields of effector cells.
Dunlop MB; Blanden RV
Immunology; 1976 Aug; 31(2):171-80. PubMed ID: 955675
[TBL] [Abstract][Full Text] [Related]
18. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
19. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.
Gooding LR
J Immunol; 1977 Mar; 118(3):920-7. PubMed ID: 191529
[TBL] [Abstract][Full Text] [Related]
20. Immunological tolerance to lymphocytic choriomeningitis virus in neonatally infected virus carrier mice: evidence supporting a clonal inactivation mechanism.
Cihak J; Lehmann-Grube F
Immunology; 1978 Feb; 34(2):265-75. PubMed ID: 304840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
